Clinical Trial

Circulating Tumor Cells (CTC) in Lung Cancer

Study Description

Circulating Tumor Cells (CTC) in Lung Cancer

The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Blood draw

Whole blood will be collected using standard phlebotomy procedures

Additional Information

Official Study Title

Circulating Tumor Cells (CTC) in Lung Cancer

Clinical Trial ID

NCT02630615

ParticipAid ID

mbkBva